Morepen Laboratories Reports Mixed Financial Results Amid Operational Challenges for Q4 2024
Morepen Laboratories recently released its financial results for the quarter ending December 2024, showcasing a strong Debtors Turnover Ratio but facing challenges with declining Profit Before Tax and Profit After Tax. The company also reported lower Operating Profit and Earnings per Share, indicating a complex financial situation.
Morepen Laboratories, a small-cap player in the Pharmaceuticals & Drugs industry, recently announced its financial results for the quarter ending December 2024. The evaluation changes reflect a notable shift in the company's score, which has seen a revision from 13 to -3 over the past three months.The financial data reveals some positive aspects for Morepen Laboratories. The Debtors Turnover Ratio has reached its highest level in the last five half-yearly periods at 5.86 times, indicating that the company has been effective in settling its debtors more quickly.
However, several challenges are evident in the latest results. The Profit Before Tax less Other Income (PBT) has recorded a significant decline, standing at Rs 29.87 crore, which is lower than the average of the previous four quarters. Similarly, the Profit After Tax (PAT) has also decreased to Rs 26.69 crore, reflecting a downward trend in profitability. Operating Profit and Operating Profit Margin have reached their lowest points in the last five quarters, suggesting a deterioration in operational efficiency. Additionally, the Earnings per Share (EPS) has fallen to Rs 0.49, indicating reduced earnings for shareholders.
Overall, Morepen Laboratories is navigating a complex financial landscape, with both strengths and weaknesses highlighted in its recent performance.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
